BSE filing, NSE: CELLO. Summary written from the filing by ALFA Finder's alert engine.
Cello World Ltd: key numbers
- Share price
- ₹335.60
- Market cap
- ₹7,413 Cr
- Revenue (annual)
- ₹2,324 Cr
- Net profit (annual)
- ₹331.5 Cr
- P/E (TTM)
- 23.7×Sector 41.7×
- Promoter holding
- 73.50%-1.50% QoQ
- FII holding
- 2.03%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Cello World Ltd
All →Cello World Price Movement Clarification
Cello World clarified that the recent increase in its security's trading volume is purely market-driven, confirming no undisclosed price-sensitive information exists.
Cello World Other Announcement
Cello World Limited filed a report certifying the completion of fractional entitlement compensation to eligible shareholders, as required by the Composite Scheme of Amalgamation.
Cello World Other Announcement
Cello World Ltd has filed its quarterly shareholding pattern disclosure as required by SEBI regulations. This is a periodic compliance filing with no actionable corporate event.
Cello World Investor Presentation: Key Takeaways
Cello World reported Q1 FY27 revenue of Rs. 527 crores with 22.2% EBITDA and 13.9% PAT margins. Results were impacted by a soft patch in consumer ware due to import transitions.
Cello World Investor Presentation: Key Takeaways
Cello World reported Q1FY27 revenue of ₹527 Cr with 13.9% PAT margin. Performance was impacted by subdued discretionary spending and steel bottle inventory shortages, countered by pricing actions and in-house manufacturing ramp-up.
Cello World Results Update
Cello World Limited reported Q1 FY27 revenue of ₹527 crore. The press release highlights performance metrics alongside operational updates.
- Value
- ₹527.0 Cr
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.